Ardea Biosciences Presents Preclinical Anti-Inflammatory Data On Its Lead MEK Inhibitor, RDEA119, At The ACG 2008 Annual Meeting
Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that a poster entitled “RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS) — induced Chronic Colitis in Mice,” was presented at the American College of Gastroenterology (ACG) 2008 Annual Meeting in Orlando, Florida.
More: continued here
Filed under: GastroIntestinal / Gastroentorology on October 13th, 2008